- Abstract viewed - 56 times
- PDF downloaded - 13 times
This study reports the experience and outcomes of a new monofocal intraocular lens (IOL) by the name of MyIOL603YP. The performance of MyIOL603YP over a 2-month follow-up period from June to December 2016 was assessed.
Twenty-nine patients, one eye from each patient, were recruited by convenience sampling method and were evaluated prospectively. Patients who were eligible to receive welfare IOLs were chosen. Detailed, preoperative examination was done, and the surgical procedure was the same for all, which was phacoemulsification with MyIOL603YP implantation with random surgeon selection. Intraoperative complications were recorded by the surgeon. Postoperative examination was done during follow-up at one week and two months post cataract operation.
Results were obtained from 22 eyes (7 defaulted). Twenty eyes (84.7%) achieved an unaided postoperative visual acuity of 6/12 or better. There were no intraoperative or postoperative complications. There was no reported inflammation two months after cataract surgery with implantation of MyIOL603YP and no posterior capsule opacification was reported.